Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have a higher risk of stroke.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Researchers found a genetic region that influences the number of coat layers in dogs.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

PRP and cell therapies may help with hair loss, but more research is needed.

Combination therapies work better than single treatments for hair loss.

PRP improves hair thickness for both genders, but only increases hair density in men.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

PRP injections may improve hair loss condition, but more research needed.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Alopecia areata affects quality of life more in adolescents than adults.

Minoxidil works faster, but ketoconazole is a safer alternative for female hair loss.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.